Immunofluorescent analysis of (-20°C Methanol) fixed HeLa cells using FITC Cytokeratin 18 antibody (FITC-66187, Clone: 1G11C4 ) at dilution of 1:200.

---

1X10^6 HeLa cells were intracellularly stained with 0.4 ug FITC Anti-Human Cytokeratin 18 (FITC-66187, Clone:1G11C4) (red), or 0.4 ug Control Antibody. Cells were fixed with 4% PFA and permeabilized with Flow Cytometry Perm Buffer (PF00011-C).

---

Immunofluorescent analysis of (-20°C Ethanol) fixed HeLa cells using CL488-66187 (Cytokeratin 18 antibody) at dilution of 1:100.

---

1X10^6 HeLa cells were intracellularly stained with 0.2 ug CoraLite® Plus 488 Anti-Human Cytokeratin 18 (CL488-66187, Clone:1G11C4) (green), and 0.2 ug Mouse IgG1 Isotype Control (CL488-66360, Clone: T1F8D3F10) (black). Cells were fixed with 4% PFA and permeabilized with 0.1% TritonX-100.

---

Immunofluorescent analysis of (-20°C Methanol) fixed HeLa cells using CoraLite®488 Cytokeratin 18 antibody (CL488-10830) at dilution of 1:200.

---

Various lysates were subjected to SDS PAGE followed by western blot with CL488-10830 (Cytokeratin 18 antibody) at dilution of 1:2000 incubated at room temperature for 1.5 hours.

---

1X10^6 HeLa cells were intracellularly stained with 0.4 ug CoraLite®488 Anti-Human Cytokeratin 18 (CL488-10830) (red), or 0.4 ug Control Antibody. Cells were fixed with 4% PFA and permeabilized with Flow Cytometry Perm Buffer (PF00011-C).

---

1X10^6 HeLa cells were intracellularly stained with 0.8 ug CoraLite® Plus 647 Anti-Human Cytokeratin 18 (CL647-66187, Clone:1G11C4) (red), or 0.8 ug Control Antibody. Cells were fixed with 4% PFA and permeabilized with Flow Cytometry Perm Buffer (PF00011-C).

---

Immunofluorescent analysis of (-20°C Methanol) fixed HepG2 cells using CoraLite® Plus 647 Cytokeratin 18 antibody (CL647-66187, Clone: 1G11C4 ) at dilution of 1:200.

---

Immunofluorescent analysis of (-20°C Ethanol) fixed HepG2 cells using CoraLite®555 Cytokeratin 18 antibody (CL555-66187, Clone: 1G11C4 ) at dilution of 1:200.

---

1X10^6 HeLa cells were intracellularly stained with 0.2 ug CoraLite®555 Anti-Human Cytokeratin 18 (CL555-66187, Clone:1G11C4) (red), or 0.2 ug Control Antibody. Cells were fixed with 4% PFA and permeabilized with Flow Cytometry Perm Buffer (PF00011-C).

---

Immunofluorescent analysis of (-20°C Ethanol) fixed HeLa cells using CL594-66187 (Cytokeratin 18 antibody) at dilution of 1:100.

---

Immunofluorescent analysis of (-20°C Ethanol) fixed HepG2 cells using CL594-66187 (Cytokeratin 18 antibody) at dilution of 1:200.

---

1X10^6 HeLa cells were intracellularly stained with 0.4 ug CoraLite®594 Anti-Human KRT18 (CL594-66187, Clone:1G11C4) (red), or 0.4 ug Mouse IgG1 Isotype Control (CL594-66360, Clone: T1F8D3F10) (blue). Cells were fixed with 4% PFA and permeabilized with Flow Cytometry Perm Buffer (PF00011-C).

---

Various lysates were subjected to SDS PAGE followed by western blot with CL594-10830 (Cytokeratin 18 antibody) at dilution of 1:2000 incubated at room temperature for 1.5 hours.

---

Immunofluorescent analysis of (-20°C Methanol) fixed HepG2 cells using CoraLite®594 Cytokeratin 18 antibody (CL594-10830) at dilution of 1:200.

---

1X10^6 HeLa cells were intracellularly stained with 0.4 ug CoraLite®594 Anti-Human Cytokeratin 18 (CL594-10830) (red), or 0.4 ug Control Antibody. Cells were fixed with 4% PFA and permeabilized with Flow Cytometry Perm Buffer (PF00011-C).

---